JAX Livestreams

Aged C57BL/6J Mice: Research Applications & Colony Management Considerations

Join JAX's Rick Huntress as he discusses the latest research from Any Schile, Ph.D. on aged mice and colony management. They'll talk about some advantages of utilizing aged mice, how experiments diffe

A View on ALS Drug Discovery - Learnings From the Front Lines of Translational Disease Modeling

Join Cat Lutz, Ph.D., Senior Director In Vivo Pharmacology & Mouse Repository at JAX as she'll discuss neurodegenerative diseases, rare diseases, and her group’s latest work in preclinical studies usi

JAX Innovation: Where We See Preclinical Research Going

Join us for the next episode of JAXLive! On Wednesday, September 16th, we will be speaking with Danielle Fontaine, Ph.D. and Michael Ellis, Ph.D. as they discuss innovation when it comes to generating

Model Generation Part 2: Building Complex Models and Embracing Genetic Diversity

Join is on Wednesday, September 9 for a follow up discussion about Model Generation. We will dive a little deeper into model generation, look into layering mutations, B6 to NODs, and more! For more in

JAXLive! Model Generation Part 1: An Introduction

Join us this week for a conversation on Model Generation. We'll cover the basics on what it is, what types of models JAX can generate, critical factors in developing the right model for you, and much

Key Considerations for NASH Models

Join Danielle Fontaine, Ph.D. and Andrew Schile, Ph.D. on Wednesday, August 26 as they discuss the NASH mouse models and what to consider when choosing the appropriate model for your study.

Part 3 of a 3-part HuMouse Series: An In Vivo CRS platform with Safety and Efficacy Applications

Join Rick Huntress and Dr. Basile Siewe on Wednesday, August 19 for the next episode of JAXLive! where they will discuss an in vivo CRS platform with both efficacy and safety applications.

Part 2 of a 3-part Humanized Mouse Series: What to Consider When Humanizing an Immunodeficient Mouse

Join Rick Huntress and Natalie Hurlen, Ph.D. on Wednesday, August 12 as they discuss humanizing immunodeficient mice. Learn more here: https://resources.jax.org/jax-blog/working-with-humanized-nsg-mic

Part 1 of a 3-part HuMouse Series: Exploring JAX NSG Platform: Specialized Humanized Mouse Models

Join Rick Huntress and Aaron Rose, Ph.D. today as they discuss the ways that JAX can support custom humanization projects, including the NBSGW or NSG-Kit (026622). Learn More at: https://www.jax.org/j

Modeling a Population: An Overview of JAX Diversity Outbred Mice

Join us today for a conversation on Diversity Outbred Mice with Kelly Brackett, Ph.D. and Elizabeth Axton, Ph.D. -- Want to learn more? Read our latest blog: https://www.jax.org/news-and-insights/2019

Tomorrow's Autoimmune Research Today: Mouse Models, Type 1 Diabetes, and More

An Interview with Professor Dave Serreze, Ph.D. and Jennifer Dwyer, Ph.D. on Type-1 Diabetes and Autoimmune diseases. Learn More Here: https://www.jax.org/explore-by-topic/diabetes/type-1-diabetes

JAXLive! A preview of Immunology Scientific Sessions -- CRS, NSG Mice, and More

Join Drs. Kyle Draheim and Dr. Jenny Morgenweck today as they give a preview of our upcoming Immunology scientific sessions on Monday, July 20.

JAX Live! Bispecific Antibody Testing

JAX LIVE! A Dialogue on Immunotoxicity and COVID-19-related CRS

Join James Keck, Ph.D. and Aaron Rose, Ph.D. as they discuss testing potential Cytokine Release Syndrome therapies for COVID-19.

T-cells, B-cells, macrophages: how to pick immunodeficient models

Join Grace Berryhill, Ph.D. and Andrew Schile, Ph.D. as they discuss the considerations in choosing an immunodeficent mouse model. Learn more at: JAX.org/Immunodeficient-Models-YT

Ready, Set Go! Getting Back to Research After COVID-19

Join Steve Rockwood and Rob Taft of The Jackson Laboratory for a discussion about what comes next after COVID-19 as researchers go back into the lab.

Taking CAR T Therapy for a Preclinical Test Drive

Join Drs. Jing Jiao and Brian Soper for a discussion evaluating CAR T therapy efficacy in preclinical mouse models.

hACE2 Transgenic Model For COVID-19 Research

In this broadcast, Drs. Cat Lutz and Qiming Wang discuss the new hACE2 transgenic platform and answer questions from viewers.

Respond and Recover: Risk Mitigation Through Cryopreservation

Linda Waterman (JAX Senior Director of Comparative Medicine and Quality) and Rob Taft (JAX Senior Services Manager) outline risk mitigation strategies you can use to preserve your research.